The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...
For decades, scientists believed that infections were determined solely by viruses and bacteria. But Professor Jean-Laurent ...
Domino's Pizza -- one of the best performing stocks of the last two decades -- headlines Monday's slate of earnings. Hims & Hers Health -- [whose shares tumbled Friday after Novo Nordisk said a shorta ...
Axios Vitals on MSN1h
Copycat Ozempic makers brace for crackdownMakers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...
Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs ...
US FDA declares Wegovy & Ozempic shortage is over and that Novo Nordisk is fully meeting or exceeding nationwide demand for all doses: Plainsboro, New Jersey Monday, February 24, ...
WEIGHT-loss drugs can be bought on the black market with no checks or consultation, The Sun has found. We obtained ...
Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See ...
AS Heart Month reminds us of the critical need to protect our cardiovascular and metabolic health, Novo Nordisk Philippines ...
These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback